Vimseltinib (romvimza) approved for use in adults to treat tenosynovial giant cell tumours
seen at 14:51, 14 August in News and communications.Vimseltinib (romvimza) approved for use in adults to treat tenosynovial giant cell tumours
seen at 14:51, 14 August in News and communications.